TY  - RPRT
TI  - A novel immunogene therapy to cancer with high tumor selectivity and safety
AU  - Wang, J.
PY  - 2025
DO  - 10.1101/2025.03.14.643237
UR  - https://www.biorxiv.org/content/10.1101/2025.03.14.643237v1
ID  - 10.1101/2025.03.14.643237
ER  -